FDA clears new dietary supplement: 3 points

Here are three points:

1. RiduZone is a naturally occurring appetite regulator and is a metabolite of oleic acid, which is part of a healthy diet.

2. The FDA conducted a comprehensive review of all available literature and data related to RiduZone.

3. RiduZone is developed by NutriForward, has exclusive rights to bring oleoylethanolamide into the market.

More articles on GI/endoscopy:
4 GI physicians in the news – Aug. 21, 2015
Exact Sciences’ price target hits $29
AGA proposes alternative to MOC recertification

Next Up in GI & Endoscopy

ConMed to end its GI product lines

Medical device company and surgical equipment manufacturer ConMed plans to exit its gastroenterology product lines. ConMed’s gastroenterology segment is projected…

Gastroenterologists find success in using AI for surveillance colonoscopy intervals

Gastroenterologists at the University of Miami Miller School of Medicine and the University of Pennsylvania Perelman School of Medicine have…

The titans of gastroenterology M&A

Here are three major GI groups leading gastroenterology practice acquisitions and ASC growth: GI Alliance Southlake, Texas-based GI Alliance is…

How AdventHealth unlocked $24M in 4 months

Next Up in GI & Endoscopy

ConMed to end its GI product lines

Gastroenterologists find success in using AI for surveillance colonoscopy intervals

The titans of gastroenterology M&A

Join the 40,000+ ASC leaders who start their day with Becker's